申请人:INTRA CELLULAR THERAPIES INC
公开号:WO2020210614A1
公开(公告)日:2020-10-15
The present invention relates to novel compounds having a capacity for PDE1 inhibition which may be used as tracers for use in diagnostic techniques, biomarkers for phosphodiesterase 1 (PDE1) in vivo, methods for treating and/or developing novel therapies for PDE1-associated conditions, and to methods of detection and treatment.